LT2575802T - Fosfaplatinos junginiai ir jų panaudojimas vėžio gydymui - Google Patents

Fosfaplatinos junginiai ir jų panaudojimas vėžio gydymui

Info

Publication number: LT2575802T
Authority: LT; Lithuania
Prior art keywords: phosphaplatins; cancers; treatment
Prior art date: 2010-06-04

Application number

LTEP11726567.8T

Other languages

English (en)

Inventor

Rathindra N. Bose

Original Assignee

Ohio University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-06-04

Filing date

2011-06-02

Publication date

2016-12-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44627266&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2575802(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-06-02 Application filed by Ohio University filed Critical Ohio University

2016-12-27 Publication of LT2575802T publication Critical patent/LT2575802T/lt

Links

206010028980 Neoplasm Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

LTEP11726567.8T 2010-06-04 2011-06-02 Fosfaplatinos junginiai ir jų panaudojimas vėžio gydymui LT2575802T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US35151410P	2010-06-04	2010-06-04
PCT/US2011/038948 WO2011153365A1 (en)	2010-06-04	2011-06-02	Phosphaplatins and their use for treatment of cancers

Publications (1)

Publication Number	Publication Date
LT2575802T true LT2575802T (lt)	2016-12-27

Family

ID=44627266

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP11726567.8T LT2575802T (lt)	2010-06-04	2011-06-02	Fosfaplatinos junginiai ir jų panaudojimas vėžio gydymui

Country Status (30)

Country	Link
US (4)	US9688709B2 (lt)
EP (1)	EP2575802B1 (lt)
JP (1)	JP5860872B2 (lt)
KR (1)	KR101775410B1 (lt)
CN (6)	CN108392490A (lt)
AP (1)	AP3480A (lt)
AU (1)	AU2011261381B2 (lt)
BR (1)	BR112012030927B1 (lt)
CA (1)	CA2800898C (lt)
CL (1)	CL2012003416A1 (lt)
CO (1)	CO6640302A2 (lt)
CY (1)	CY1118466T1 (lt)
DK (1)	DK2575802T3 (lt)
EA (1)	EA021526B1 (lt)
ES (1)	ES2606855T3 (lt)
HR (1)	HRP20170225T1 (lt)
HU (1)	HUE030249T2 (lt)
IL (1)	IL223405B (lt)
LT (1)	LT2575802T (lt)
MX (1)	MX2012014174A (lt)
MY (1)	MY162902A (lt)
NZ (1)	NZ603952A (lt)
PL (1)	PL2575802T3 (lt)
PT (1)	PT2575802T (lt)
RS (1)	RS55714B1 (lt)
SG (1)	SG185722A1 (lt)
SI (1)	SI2575802T1 (lt)
SM (1)	SMT201700056B (lt)
WO (1)	WO2011153365A1 (lt)
ZA (1)	ZA201209007B (lt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN108392490A (zh)	2010-06-04	2018-08-14	俄亥俄大学	磷铂及其在治疗癌症中的用途
CA2818933A1 (en) *	2011-01-12	2012-07-19	Ohio University	Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof
JP6027619B2 (ja) *	2011-10-05	2016-11-16	ラシンドラ・エヌ・ボーズ	ホスファプラチン系抗腫瘍剤の大規模調製のための効率的プロセス
WO2013052839A1 (en) *	2011-10-05	2013-04-11	Bose Rathindra N	Efficient processes for large scale preparation of phosphaplatins antitumor agents
DK2855496T3 (en) *	2012-05-24	2017-03-27	Phosplatin Therapeutics Llc	PROCEDURES FOR SYNTHESIS AND PURIFICATION OF PHOSPHAPLATIN COMPOUNDS AND APPLICATIONS THEREOF
US9333211B2 (en) *	2013-02-22	2016-05-10	University Of Houston System	Phosphaplatin mediated modulation of pigment epithelial derived factor and uses thereof
US20150231151A1 (en) *	2014-02-19	2015-08-20	University Of Houston System	Compositions and methods for the treatment of neurodegenerative diseases
TWI798175B (zh) *	2016-04-06	2023-04-11	美商弗斯普萊汀治療股份有限公司	磷酸鉑(phosphaplatin)液態調配物
KR20190103258A (ko) *	2017-01-06	2019-09-04	포스플라틴 테라퓨틱스 엘엘씨	뼈 또는 혈액 암의 치료를 위한 치료제로서의 포스파플라틴 화합물
ES2971716T3 (es) *	2017-09-08	2024-06-06	Promontory Therapeutics Inc	Compuestos de fosfaplatino como agentes inmunomoduladores y usos terapéuticos de los mismos
EP4232044A1 (en) *	2020-10-20	2023-08-30	Promontory Therapeutics Inc.	Phosphaplatin compounds as therapeutic agents selectively targeting highly glycolytic tumor cells and methods thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4234500A (en)	1979-03-07	1980-11-18	Engelhard Minerals & Chemicals Corporation	Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
US4291027A (en)	1979-03-07	1981-09-22	Engelhard Minerals & Chemicals Corp.	Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
CA2017739A1 (en)	1989-07-18	1991-01-18	Leslie S. Hollis	Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents
AUPR330201A0 (en)	2001-02-23	2001-03-22	University Of Sydney, The	Metal complexes and therapeutic uses thereof
DE10314780A1 (de)	2003-03-19	2004-09-30	Ktb Tumorforschungsgesellschaft Mbh	Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden
CA2524478A1 (en)	2003-05-02	2004-11-18	Aronex Pharmaceuticals, Inc.	Lipid platinum complexes and methods of use thereof
WO2005000858A2 (en)	2003-06-27	2005-01-06	Akira Odani	Bisphosphonate complexes
WO2009008345A1 (ja)	2007-07-06	2009-01-15	Tmrc Co., Ltd.	金属錯体化合物、これを有効成分とする癌治療剤組成物および該金属錯体化合物用の中間体
EP2668949A1 (en) *	2007-08-06	2013-12-04	Ohio University	Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
WO2011125911A1 (ja)	2010-03-31	2011-10-13	国立大学法人金沢大学	金属錯体およびこれを有効成分として含有する抗がん剤
CN108392490A (zh)	2010-06-04	2018-08-14	俄亥俄大学	磷铂及其在治疗癌症中的用途
CA2818933A1 (en) *	2011-01-12	2012-07-19	Ohio University	Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof
JP6027619B2 (ja) *	2011-10-05	2016-11-16	ラシンドラ・エヌ・ボーズ	ホスファプラチン系抗腫瘍剤の大規模調製のための効率的プロセス

2011
- 2011-06-02 CN CN201810150470.4A patent/CN108392490A/zh active Pending
- 2011-06-02 CN CN201810150614.6A patent/CN108299508A/zh not_active Withdrawn
- 2011-06-02 EA EA201270812A patent/EA021526B1/ru unknown
- 2011-06-02 US US13/701,313 patent/US9688709B2/en active Active
- 2011-06-02 CN CN201810150496.9A patent/CN108409795A/zh active Pending
- 2011-06-02 CN CN201810150487.XA patent/CN108210516A/zh active Pending
- 2011-06-02 CN CN201810150598.0A patent/CN108186651A/zh active Pending
- 2011-06-02 DK DK11726567.8T patent/DK2575802T3/en active
- 2011-06-02 PL PL11726567T patent/PL2575802T3/pl unknown
- 2011-06-02 JP JP2013513350A patent/JP5860872B2/ja active Active
- 2011-06-02 EP EP11726567.8A patent/EP2575802B1/en active Active
- 2011-06-02 AP AP2012006594A patent/AP3480A/xx active
- 2011-06-02 SG SG2012086229A patent/SG185722A1/en unknown
- 2011-06-02 CA CA2800898A patent/CA2800898C/en active Active
- 2011-06-02 BR BR112012030927-7A patent/BR112012030927B1/pt active IP Right Grant
- 2011-06-02 MY MYPI2012005178A patent/MY162902A/en unknown
- 2011-06-02 KR KR1020137000158A patent/KR101775410B1/ko not_active Application Discontinuation
- 2011-06-02 CN CN2011800387165A patent/CN103037859A/zh active Pending
- 2011-06-02 ES ES11726567.8T patent/ES2606855T3/es active Active
- 2011-06-02 HU HUE11726567A patent/HUE030249T2/en unknown
- 2011-06-02 MX MX2012014174A patent/MX2012014174A/es active IP Right Grant
- 2011-06-02 RS RS20170139A patent/RS55714B1/sr unknown
- 2011-06-02 SI SI201131103A patent/SI2575802T1/sl unknown
- 2011-06-02 WO PCT/US2011/038948 patent/WO2011153365A1/en active Application Filing
- 2011-06-02 PT PT117265678T patent/PT2575802T/pt unknown
- 2011-06-02 NZ NZ603952A patent/NZ603952A/en unknown
- 2011-06-02 LT LTEP11726567.8T patent/LT2575802T/lt unknown
- 2011-06-02 AU AU2011261381A patent/AU2011261381B2/en active Active
2012
- 2012-11-28 ZA ZA2012/09007A patent/ZA201209007B/en unknown
- 2012-12-03 IL IL223405A patent/IL223405B/en active IP Right Grant
- 2012-12-04 CL CL2012003416A patent/CL2012003416A1/es unknown
- 2012-12-04 CO CO12219958A patent/CO6640302A2/es not_active Application Discontinuation
2016
- 2016-12-22 CY CY20161101332T patent/CY1118466T1/el unknown
2017
- 2017-01-25 SM SM201700056T patent/SMT201700056B/it unknown
- 2017-02-10 HR HRP20170225TT patent/HRP20170225T1/hr unknown
- 2017-05-24 US US15/604,237 patent/US10364264B2/en active Active
- 2017-05-24 US US15/604,209 patent/US10385083B2/en active Active
2019
- 2019-06-26 US US16/453,303 patent/US10759820B2/en active Active

Also Published As

Publication number	Publication date
CY1118466T1 (el)	2017-07-12
DK2575802T3 (en)	2017-01-09
CA2800898C (en)	2018-12-04
SI2575802T1 (sl)	2017-03-31
SMT201700056B (it)	2017-03-08
IL223405B (en)	2018-11-29
KR101775410B1 (ko)	2017-09-06
HRP20170225T1 (hr)	2017-04-07
CN108186651A (zh)	2018-06-22
EP2575802A1 (en)	2013-04-10
BR112012030927A2 (pt)	2017-12-05
US20130064902A1 (en)	2013-03-14
CN108299508A (zh)	2018-07-20
CO6640302A2 (es)	2013-03-22
EP2575802B1 (en)	2016-11-16
WO2011153365A1 (en)	2011-12-08
US10759820B2 (en)	2020-09-01
HUE030249T2 (en)	2017-04-28
AP2012006594A0 (en)	2012-12-31
AU2011261381A1 (en)	2013-01-10
ZA201209007B (en)	2013-08-28
US9688709B2 (en)	2017-06-27
CL2012003416A1 (es)	2013-09-06
CN108210516A (zh)	2018-06-29
CA2800898A1 (en)	2011-12-08
US20170327522A1 (en)	2017-11-16
PL2575802T3 (pl)	2017-04-28
CN103037859A (zh)	2013-04-10
MY162902A (en)	2017-07-31
US10385083B2 (en)	2019-08-20
SG185722A1 (en)	2013-01-30
JP5860872B2 (ja)	2016-02-16
AP3480A (en)	2015-12-31
US10364264B2 (en)	2019-07-30
BR112012030927B1 (pt)	2021-09-21
US20170327521A1 (en)	2017-11-16
JP2013529219A (ja)	2013-07-18
KR20130095244A (ko)	2013-08-27
NZ603952A (en)	2014-07-25
MX2012014174A (es)	2013-07-03
PT2575802T (pt)	2016-12-27
CN108392490A (zh)	2018-08-14
CN108409795A (zh)	2018-08-17
AU2011261381B2 (en)	2015-04-02
EA021526B1 (ru)	2015-07-30
EA201270812A1 (ru)	2013-05-30
ES2606855T3 (es)	2017-03-28
US20190315789A1 (en)	2019-10-17
RS55714B1 (sr)	2017-07-31

Publication	Publication Date	Title
IL276362A (en)	2020-08-31	Cancer treatment methods
IL248530A0 (en)	2016-12-29	Biomarkers and treatment methods
HRP20170225T1 (hr)	2017-04-07	Fosfoplatini i njihova uporaba za liječenje karcinoma
HRP20171352T1 (hr)	2017-11-03	Wnt-antagonisti i postupci liječenja
ZA201207574B (en)	2014-09-25	Phytocannabinoids in the treatment of cancer
SG10201508495VA (en)	2015-11-27	Combination treatment of cancer
IL222227A0 (en)	2012-12-31	Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
EP2539005A4 (en)	2015-12-23	ORAL PIECE AND METHODS OF USING THE SAME
ZA201300218B (en)	2013-09-25	Treatment of blood cancer
HK1189272A1 (zh)	2014-05-30	治療癌症的方法
EP2574172A4 (en)	2013-10-30	MATERIALS AND METHOD FOR TREATING INFLAMMATION
IL256026B (en)	2019-08-29	Treatment methods
EP2640390A4 (en)	2014-08-06	METHODS OF TREATING CANCER
EP2547368A4 (en)	2014-08-06	METHOD AND COMPOSITIONS FOR CANCER TREATMENT
EP2709730A4 (en)	2015-04-01	TREATMENT AND PROGNOSIS OF CANCER
GB201718726D0 (en)	2017-12-27	Phytocannabinoids in the treatment of cancer
EP2574194A4 (en)	2014-01-15	MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT
GB201017354D0 (en)	2010-11-24	Treatment of cancer
GB201017356D0 (en)	2010-11-24	Combination treatment of cancer
GB201002499D0 (en)	2010-03-31	Treatment of tumours
HUP1000688A2 (en)	2012-08-28	Use of trifluoro-phthalimides in the treatment of cancer
ZA201301175B (en)	2014-04-30	Biomarkers and methods of treatment